Table 1.
Intervention characteristics of included studies.
| Study/ID | Hospitalization time | Type | Histological type (observation/control) | Clinical stage | N (observation/control) | Regimen | |||
|---|---|---|---|---|---|---|---|---|---|
| Squamous | Adeno | Adenosquamous | Observation | Control | |||||
| Lu et al[16] | 2017.01–2020.01 | RCT | 66/32 | 12/6 | 0 | IB2–IVA | 78/38 | E + CCRT (cisplatin, qw) | CCRT (cisplatin, qw) |
| Chen and Fu[17] | 2016.02–2018.02 | NRCT | 49/46 | 11/10 | 0 | IIB–IVA | 60/56 | E + CCRT (TP) | CCRT(TP) |
| Dili et al[18] | 2015.01–2017.05 | Cohort study | 54/58 | 24/28 | 0 | IIB–IVA | 78/86 | E + CCRT (DDP, qw) | CCRT (DDP, qw) |
| Tang[19] | 2017.07–2018.11 | NRCT | 27/27 | 3/3 | 0 | IIB–IVA | 30/30 | E + CCRT (DDP, qw) | CCRT (DDP, qw) |
| Xu et al[20] | 2014.02–2016.05 | RCT | 26/28 | 6/6 | 0 | IIB–IVA | 32/34 | E + CCRT (DDP, qw) + thermotherapy | CCRT (DDP, qw) + thermotherapy |
| Fan et al[21] | 2013.02–2014.02 | RCT | 20/21 | 8/7 | 0 | IIB–IVA | 28/28 | E + CCRT (DDP, qw) | CCRT (DDP, qw) |
| Luo[22] | 2011.01–2014.01 | RCT | 20/22 | 13/11 | 0 | IIB–IVA | 33/33 | E + CCRT (liposome, qw) | CCRT (liposome, qw) |
| Liu et al[23] | 2007.01–2008.12 | NRCT | 25/25 | 0 | 0 | III bulky | 25/25 | E + CCRT (DDP, qw) + SC (TP) | CCRT (DDP, qw) + SC (TP) |
| Ke et al[24] | 2009.10–2010.1 | RCT | 18/19 | 8/7 | 0 | IIB–IVA | 26/26 | E + CCRT (DDP, qw) | CCRT (DDP, qw) |
| Shu et al[15] | 2019.06–2020.12 | RCT | 48/43 | 0 | 0 | IB3–IVA | 48/43 | E + CCRT (TP) | CCRT (TP) |
| Zhao et al[25] | Unknown | RCT | 15/15 | 5/5 | 5/5 | IIB–IV | 25/25 | E + CCRT (DDP qw + Hu po bid) | CC (DDP qw + Hu po bid) |
| Zhang[26] | 2010.2–2013.6 | Cohort study | 49/40 | 8/6 | 0 | IIB–IVA | 57/46 | E + CCRT (DDP, qw) | CC (DDP, qw) |
| Li[27] | 2017.1–2020.2 | NRCT | 28/27 | 8/7 | 0 | IIB–IIIB | 36/34 | E + CCRT (DDP, qw) | CC (DDP, qw) |
CCRT = concurrent chemoradiotherapy, DDP = cisplatin, E + CCRT = endostar + concurrent chemoradiotherapy, NRCT = nonrandomized controlled trial, RCT = randomized controlled trial, TP = triptolide.